Pre-AIDS mortality and its association with HIV disease progression in haemophilic men, injecting drug users and homosexual men

AIDS

Volumn 14, Issue 12, 2000, Pages 1829-1837

  Prins, Maria ^a   Sabin, Caroline A ^b   Lee, Christine A ^b   Devereux, Helen ^b   Coutinho, Roel A ^a,c  

^a MUNICIPAL HEALTH SERVICE   (Netherlands)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

CD4+ T cell count; Haemophilic men; HIV disease progression; Homosexual men; Injecting drug users; Pre AIDS mortality; Viral load

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEMOPHILIA; HEPATITIS C; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NETHERLANDS; PRIORITY JOURNAL; SEROCONVERSION; UNITED KINGDOM; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DISEASE PROGRESSION; HEMOPHILIA A; HIV INFECTIONS; HIV SEROPOSITIVITY; HOMOSEXUALITY, MALE; HUMANS; LONDON; MALE; NETHERLANDS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0033827395     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200008180-00019     Document Type: Article

References (37)

1. Predictors of mortality in the Amsterdam cohort of human immunodeficiency virus (HIV)-positive and HIV-negative drug users
2. Pre-AIDS mortality from natural causes associated with HIV disease progression: Evidence from the European Seroconverter Study among injecting drug users
3. Two-year HIV-1 associated mortality in a Ugandan rural population
4. Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population
5. The progression of HCV-associated liver disease in a cohort of haemophilic patients
6. High risk of non-A, non-B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: Effects of prophylactic immune serum globulin
7. Prevalence, incidence and risk factors of hepatitis C virus infection among drug users in Amsterdam
8. Hepatitis C
9. High mortality among HIV-infected injecting drug users without AIDS-diagnosis: Implications for HIV-infection epidemic modellers?
10. Comparison of progression and non-progression in injecting drug users and homosexual men with documented dates of HIV-1 seroconversion
11. Sexual transmission of hepatitis C virus: Cohort study (1981-1989) among European homosexual men
12. Prevalence of anti-HCV antibodies confirmed by recombinant immunoblot in different population subsets in The Netherlands
13. Symptomless HIV infection after more than ten years
14. The natural history of human immunodeficiency virus infection in a haemophiliac cohort
15. Prevalence and risk factors of HIV infections among drug users and drug-using prostitutes in Amsterdam
16. Risk factors and prevalence of HIV antibodies in homosexual men in the Netherlands
17. Morbidity and mortality from transfusion-transmitted disease in haemophilia
18. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: Prospective multicentre study. Swiss HIV Cohort Study
19. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection
20. Human immunodeficiency virus infection and infective endocarditis among injecting drug users
21. Spectrum of disease in persons with human immunodeficiency virus infection in the United States
22. Incidence and risk factors for pneumonia in HIV infected and non- infected drug users
23. Drug smoking, Pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug users
24. Community-acquired pneumonia in a cohort of former injection drug users with and without human immunodeficiency virus infection: Incidence, etiologies, and clinical aspects
25. Human immunodeficiency virus type 1 infection: Relationship of risk group and age to rate of progression to AIDS. Transfusion Safety Study Group
26. Impact of AIDS on premature mortality in Amsterdam, 1982-1992
27. Increased incidence of cancer among homosexual men, New York City and San Francisco, 1978-1990
28. Spectrum of AIDS-associated malignant disorders
29. Risk of cancer in people with AIDS
30. Expanded European AIDS case definition
31. AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function: Markers with reciprocal predictive value over time after seroconversion
32. The relative prognostic value of plasma HIV RNA levels and CD4 lymphocyte counts in advanced HIV infection
33. Differences in progression to AIDS between injection drug users and homosexual men with documented dates of seroconversion
34. Projecting disease when death is likely
35. The incubation period to AIDS in injecting drug users estimated from prevalent cohort data, accounting for death prior to an AIDS diagnosis
36. Geographical variation in disease progression in HIV-1 seroconverted injecting drug users in Europe?